Prevention of hepatocellular carcinoma development associated with chronic hepatitis by anti-Fas ligand antibody therapy

Journal of Experimental Medicine

Volumn 196, Issue 8, 2002, Pages 1105-1111

  Nakamoto, Yasunari ^a   Kaneko, Shuichi ^a   Fan, Hong ^a   Momoi, Takashi ^b   Tsutsui, Hiroko ^c   Nakanishi, Kenji ^c   Kobayashi, Kenichi ^a   Suda, Takashi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Apoptosis; Cancer; Cytotoxic T lymphocytes; Disease model; Inflammation

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY FAS LIGAND; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL KILLING; CELL PROLIFERATION; CHRONIC HEPATITIS; CHRONIC INFLAMMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; IMMUNE RESPONSE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR;

ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; DISEASE MODELS, ANIMAL; FAS LIGAND PROTEIN; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B, CHRONIC; HEPATOCYTES; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS, EXPERIMENTAL; LYMPHOCYTE DEPLETION; MEMBRANE GLYCOPROTEINS; MICE; MICE, TRANSGENIC; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0037152184     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20020633     Document Type: Article

References (25)

1. Chisari, F.V., and C. Ferrari. 1995. Hepatitis B virus immunopathology. Springer Semin. Immunopathol. 17:261-281.
2. Bertoletti, A., and M.K. Maini. 2000. Protection or damage: A dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection? Curr. Opin. Microbiol. 3:387-392.
3. Ando, K., T. Moriyama, L.G. Guidotti, S. Wirth, R.D. Schreiber, H.J. Schlicht, S. Huang, and F.V. Chisari. 1993. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J. Exp. Med. 178:1541-1554.
4. Suda, T., T. Okazaki, Y. Naito, T. Yokota, N. Arai, S. Ozaki, K. Nakao, and S. Nagata. 1995. Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 154:3806-3813.
5. Lowin, B., M. Hahne, C. Mattmann, and J. Tschopp. 1994. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature. 370:650-652.
6. Kondo, T., T. Suda, H. Fukuyama, M. Adachi, and S. Nagata. 1997. Essential roles of the Fas ligand in the development of hepatitis. Nat. Med. 3:409-413.
7. Nakamoto, Y., L.G. Guidotti, V. Pasquetto, R.D. Schreiber, and F.V. Chisari. 1997. Differential target cell sensitivity to CTL-activated death pathways in hepatitis B virus transgenic mice. J. Immunol. 158:5692-5697.
8. Robinson, W.S., L. Klote, and N. Aoki. 1990. Hepadnaviruses in cirrhotic liver and hepatocellular carcinoma. J. Med. Virol. 31:18-32.
9. Colombo, M., R. de Franchis, E. Del Ninno, A. Sangiovanni, C. De Fazio, M. Tommasini, M.F. Donato, A. Piva, V. Di Carlo, and N. Dioguardi. 1991. Hepatocellular carcinoma in Italian patients with cirrhosis. N. Engl. J. Med. 325:675-680.
10. Tsukuma, H., T. Hiyama, S. Tanaka, M. Nakao, T. Yabuuchi, T. Kitamura, K. Nakanishi, I. Fujimoto, A. Inoue, H. Yamazaki, et al. 1993. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N. Engl. J. Med. 328:1797-1801.
11. Chisari, F.V., K. Klopchin, T. Moriyama, C. Pasquinelli, H.A. Dunsford, S. Sell, C.A. Pinkert, R.L. Brinster, and R.D. Palmiter. 1989. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell. 59:1145-1156.
12. Nakamoto, Y., L.G. Guidotti, C.V. Kuhlen, P. Fowler, and F.V. Chisari. 1998. Immune pathogenesis of hepatocellular carcinoma. J. Exp. Med. 188:341-350.
13. Chisari, F.V., P. Filippi, A. McLachlan, D.R. Milich, M. Riggs, S. Lee, R.D. Palmiter, C.A. Pinkert, and R.L. Brinster. 1986. Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice. J. Virol. 60:880-887.
14. Wirth, S., L.G. Guidotti, K. Ando, H.J. Schlicht, and F.V. Chisari. 1995. Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice. J. Immunol. 154:2504-2515.
15. Moriyama, T., S. Guilhot, K. Klopchin, B. Moss, C.A. Pinkert, R.D. Palmiter, R.L. Brinster, O. Kanagawa, and F.V. Chisari. 1990. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science. 248:361-364.
16. Miwa, K., H. Hashimoto, T. Yatomi, N. Nakamura, S. Nagata, and T. Suda. 1999. Therapeutic effect of an anti-Fas ligand mAb on lethal graft-versus-host disease. Int. Immunol. 11:925-931.
17. Matsui, K., T. Yoshimoto, H. Tsutsui, Y. Hyodo, N. Hayashi, K. Hiroishi, N. Kawada, H. Okamura, K. Nakanishi, and K. Higashino. 1997. Propionibacterium acnes treatment diminishes CD4+ NK1.1+ T cells but induces type I T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells. J. Immunol. 159:97-106.
18. Urase, K., E. Fujita, Y. Miho, Y. Kouroku, T. Mukasa, Y. Yagi, M.Y. Momoi, and T. Momoi. 1998. Detection of activated caspase-3 (CPP32) in the vertebrate nervous system during development by a cleavage site-directed antiserum. Brain Res. Dev. Brain Res. 111:77-87.
19. Miwa, K., M. Asano, R. Horai, Y. Iwakura, S. Nagata, and T. Suda. 1998. Caspase 1-independent IL-1beta release and inflammation induced by the apoptosis inducer Fas ligand. Nat. Med. 4:1287-1292.
20. Tsutsui, H., N. Kayagaki, K. Kuida, H. Nakano, N. Hayashi, K. Takeda, K. Matsui, S. Kashiwamura, T. Hada, S. Akira, et al. 1999. Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice. Immunity. 11:359-367.
21. Seino, K., N. Kayagaki, K. Okumura, and H. Yagita. 1997. Antitumor effect of locally produced CD95 ligand. Nat. Med. 3:165-170.
22. Kang, S.M., D.B. Schneider, Z. Lin, D. Hanahan, D.A. Dichek, P.G. Stock, and S. Baekkeskov. 1997. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nat. Med. 3:738-743.
23. Allison, J., H.M. Georgiou, A. Strasser, and D.L. Vaux. 1997. Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts. Proc. Natl. Acad. Sci. USA. 94:3943-3947.
24. Desbarats, J., and M.K. Newell. 2000. Fas engagement accelerates liver regeneration after partial hepatectomy. Nat. Med. 6:920-923.
25. Guidotti, L.G., B. Matzke, H. Schaller, and F.V. Chisari. 1995. High-level hepatitis B virus replication in transgenic mice. J. Virol. 69:6158-6169.